Hengsai Biotechnology
PrivateLast Round
Strategic
Dec 30, 2025
Total Funding Raised
$22.87M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hengsai Biotechnology is a biotechnology company that develops therapeutic dendritic cell (DC) vaccines for the treatment of tumors, chronic viral infections, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hengsai Biotechnology Comparables
Compare Hengsai Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CoImmune, Inc. | 82% | |
| Elios Therapeutics | 80% | |
| Diakonos Oncology | 78% | |
Hengsai Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 30, 2025 | ||||
| Series A Extension | Jan 17, 2024 | ||||
| Series A | Nov 27, 2023 | ||||
| Pre Seed | Apr 20, 2022 |
Hengsai Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 中山创业投资有限公司 | Series A Extension |
| Fuhui Venture Capital | Series A, Pre Seed |
| Beijing Chengming Private Equity Fund Management Co., Ltd. | Series A Extension |
| Zhongshan Cuiheng Group Co., Ltd. | Series A Extension |
| Tasly Capital | Strategic |
| Zhongshan Venture Capital Co., Ltd. | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 30, 2025
Led by Tasly Capital
- Jan 17, 2024
$4M raised from Beijing Chengming and Zhongshan Venture Capital.
Hengsai Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hengsai Biotechnology's valuation, stock price, and market status.